+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Point-of-Care Glucose Testing Market by Product Type (Continuous Glucose Monitoring Devices, Glucose Meters, Sensors), End User (Ambulatory Surgical Centers, Diagnostic Laboratories, Home Care), Distribution Channel, Test Type, Technology, Portability - Global Forecast 2025-2030- Product Image
Point-of-Care Glucose Testing Market by Product Type (Continuous Glucose Monitoring Devices, Glucose Meters, Sensors), End User (Ambulatory Surgical Centers, Diagnostic Laboratories, Home Care), Distribution Channel, Test Type, Technology, Portability - Global Forecast 2025-2030- Product Image
Sale

Point-of-Care Glucose Testing Market by Product Type (Continuous Glucose Monitoring Devices, Glucose Meters, Sensors), End User (Ambulatory Surgical Centers, Diagnostic Laboratories, Home Care), Distribution Channel, Test Type, Technology, Portability - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5305543
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The point-of-care glucose testing market is rapidly evolving, driven by accelerating technology advancements and increasing demand for swift, accurate, and patient-centric diagnostic solutions. As care settings diversify and healthcare stakeholders prioritize efficiency, point-of-care glucose testing emerges as a critical component for timely clinical decision-making.

Market Snapshot: Point-of-Care Glucose Testing Market Size and Growth

The point-of-care glucose testing market grew from USD 7.20 billion in 2024 to USD 7.77 billion in 2025. It is expected to maintain a CAGR of 7.57%, reaching USD 11.16 billion by 2030. This growth underscores expanding adoption across clinical environments and patient home settings, spurred by continuous technology integration and evolving patient expectations.

Scope & Segmentation

This report provides in-depth coverage and forecasting for the point-of-care glucose testing market, focusing on the following segments and regions:

  • Product Type: Continuous glucose monitoring devices (intermittently scanned, real time), glucose meters, sensors (enzymatic, optical), software apps, and test strips.
  • End User: Ambulatory surgical centers, diagnostic laboratories (hospital based labs, independent labs), home care (assisted home care, self monitoring), and hospitals & clinics (large hospitals, small clinics).
  • Distribution Channel: Direct sales, hospital pharmacies, online pharmacies (manufacturer websites, third-party marketplaces), and retail pharmacies.
  • Test Type: Invasive, minimally invasive, and noninvasive testing methods.
  • Technology: Colorimetric, electrochemical, and photometric techniques.
  • Portability: Benchtop and portable devices supporting diverse clinical and home settings.
  • Geographic Coverage: Americas (including detailed breakdowns for the United States, Canada, Mexico, Brazil, Argentina), Europe, the Middle East & Africa (covering the United Kingdom, Germany, France, Russia, and others), and Asia-Pacific (China, India, Japan, Australia, South Korea, and further regional markets).
  • Company Coverage: Leading and emerging market participants such as Abbott Laboratories, F. Hoffmann-La Roche Ltd, Dexcom, Inc., Medtronic plc, Johnson & Johnson, and others central to ecosystem innovation and competition.

Key Takeaways: Strategic Insights for Decision-Makers

  • Recent advancements in microelectronics and wireless connectivity are redefining how glucose data is captured, analyzed, and communicated in real time across care settings.
  • Integrating digital health platforms and artificial intelligence has shifted the market emphasis from simple measurement to proactive disease management, enabling continuous monitoring and predictive analytics.
  • Segment diversity, including differing needs between large hospitals and small clinics, shapes device design and integration requirements across the value chain.
  • Regional adoption patterns reflect economic and infrastructure disparities; tailored solutions are essential to meet specific market dynamics in both developed and emerging regions.
  • Manufacturers are leveraging strategic alliances and acquisitions to strengthen R&D capabilities and expand into adjacent healthcare technology markets.

Tariff Impact: Navigating U.S. Tariffs on Supply Chains and Pricing

The introduction of United States tariffs in 2025 has influenced supply chain decisions within the point-of-care glucose testing market. Increased import duties on key components have elevated production costs, prompting manufacturers to consider nearshoring, regional partnerships, and new sourcing arrangements. Supply chain resilience and proactive risk management are now central to pricing and margin strategies, while modular product design enables flexible adaptation to shifting regulatory and trade environments.

Methodology & Data Sources

This research is grounded in primary interviews with industry executives, clinicians, procurement experts, and payers. It is supported by comprehensive secondary data from regulatory filings, clinical publications, patent databases, and corporate disclosures. Quantitative modeling and expert validation ensure that insights are accurate and reflect current industry realities.

Why This Report Matters

  • Gain a panoramic view of point-of-care glucose testing trends, innovation triggers, and market segmentation for informed business planning.
  • Benchmark strategic initiatives, investment opportunities, and competitive moves of industry leaders and disruptors shaping the market’s future.
  • Inform regulatory, procurement, and partnership strategies for successful market entry, expansion, or optimization across global regions.

Conclusion

Senior decision-makers can rely on this comprehensive analysis to anticipate market changes, refine strategic direction, and seize growth opportunities within the point-of-care glucose testing ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of non-invasive glucose sensors leveraging advanced optical technologies for improved patient compliance
5.2. Expansion of smartphone-connected blood glucose meters with AI-driven analytics for personalized insulin dosing recommendations
5.3. Growth of portable continuous glucose monitoring wearable patches offering real-time data integration with health apps
5.4. Development of multiplexed point-of-care devices measuring glucose alongside other biomarkers for comprehensive metabolic profiling
5.5. Surge in adoption of telemedicine-integrated glucose monitoring systems enabling remote clinician intervention and data sharing
5.6. Increasing partnerships between device manufacturers and pharmaceutical companies to develop companion diagnostics for diabetes therapeutics
5.7. Emergence of IoMT-enabled glucose testing devices supporting cloud-based data management and predictive analytics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Point-of-Care Glucose Testing Market, by Product Type
8.1. Introduction
8.2. Continuous Glucose Monitoring Devices
8.2.1. Intermittently Scanned
8.2.2. Real Time
8.3. Glucose Meters
8.4. Sensors
8.4.1. Enzymatic
8.4.2. Optical
8.5. Software Apps
8.6. Test Strips
9. Point-of-Care Glucose Testing Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Diagnostic Laboratories
9.3.1. Hospital Based Labs
9.3.2. Independent Labs
9.4. Home Care
9.4.1. Assisted Home Care
9.4.2. Self Monitoring
9.5. Hospitals & Clinics
9.5.1. Large Hospitals
9.5.2. Small Clinics
10. Point-of-Care Glucose Testing Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. Hospital Pharmacies
10.4. Online Pharmacies
10.4.1. Manufacturer Websites
10.4.2. Third Party Marketplaces
10.5. Retail Pharmacies
11. Point-of-Care Glucose Testing Market, by Test Type
11.1. Introduction
11.2. Invasive
11.3. Minimally Invasive
11.4. Non Invasive
12. Point-of-Care Glucose Testing Market, by Technology
12.1. Introduction
12.2. Colorimetric
12.3. Electrochemical
12.4. Photometric
13. Point-of-Care Glucose Testing Market, by Portability
13.1. Introduction
13.2. Benchtop
13.3. Portable
14. Americas Point-of-Care Glucose Testing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Point-of-Care Glucose Testing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Point-of-Care Glucose Testing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. F. Hoffmann-La Roche Ltd
17.3.3. Dexcom, Inc.
17.3.4. Medtronic plc
17.3.5. Johnson & Johnson
17.3.6. Ascensia Diabetes Care Holdings AG
17.3.7. Nova Biomedical Corporation
17.3.8. Becton, Dickinson and Company
17.3.9. Sinocare Inc.
17.3.10. Nipro Corporation
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. POINT-OF-CARE GLUCOSE TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. POINT-OF-CARE GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. POINT-OF-CARE GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. POINT-OF-CARE GLUCOSE TESTING MARKET: RESEARCHAI
FIGURE 28. POINT-OF-CARE GLUCOSE TESTING MARKET: RESEARCHSTATISTICS
FIGURE 29. POINT-OF-CARE GLUCOSE TESTING MARKET: RESEARCHCONTACTS
FIGURE 30. POINT-OF-CARE GLUCOSE TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. POINT-OF-CARE GLUCOSE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY INTERMITTENTLY SCANNED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY INTERMITTENTLY SCANNED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REAL TIME, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REAL TIME, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ENZYMATIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ENZYMATIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OPTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OPTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SOFTWARE APPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SOFTWARE APPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST STRIPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITAL BASED LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITAL BASED LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ASSISTED HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ASSISTED HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SELF MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SELF MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SMALL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SMALL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY INVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY NON INVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY NON INVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COLORIMETRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COLORIMETRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ELECTROCHEMICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ELECTROCHEMICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PHOTOMETRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PHOTOMETRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BENCHTOP, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BENCHTOP, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 151. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 154. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 155. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 156. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 157. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 160. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 161. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 162. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 163. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 164. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 165. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 168. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 169. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 170. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 171. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 172. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 173. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
TABLE 174. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
TABLE 175. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 178. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 179. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 181. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 184. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 185. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 186. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 187. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 192. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 193. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 194. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 195. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
TABLE 198. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
TABLE 297. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. GERMANY POINT-OF-CARE GLUCOSE TEST

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Dexcom, Inc.
  • Medtronic plc
  • Johnson & Johnson
  • Ascensia Diabetes Care Holdings AG
  • Nova Biomedical Corporation
  • Becton, Dickinson and Company
  • Sinocare Inc.
  • Nipro Corporation

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.77 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.16 Billion
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Blood Glucose Testing Market by Product Type (Blood Glucose Meters, Control Solutions, Lancets), Technology (Electrochemical Sensors, Optical Techniques, Thermal Techniques), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Blood Glucose Testing Market by Product Type (Blood Glucose Meters, Control Solutions, Lancets), Technology (Electrochemical Sensors, Optical Techniques, Thermal Techniques), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Point-of-Care Glucose Testing - Global Strategic Business Report - Product Image

Point-of-Care Glucose Testing - Global Strategic Business Report

  • Report
  • 201 Pages
  • Global
From
Point-of-Care Glucose Testing: Market Share, and Growth Analysis by Product Type (Blood Glucose Meters, Continuous Glucose Monitoring Systems), Application, End User, Technology - Product Image

Point-of-Care Glucose Testing: Market Share, and Growth Analysis by Product Type (Blood Glucose Meters, Continuous Glucose Monitoring Systems), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Point-of-Care Glucose Testing Market Report 2025 - Product Image

Point-of-Care Glucose Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Blood Glucose Monitoring Market by Application (Gestational Diabetes, Type 1 Diabetes, Type 2 Diabetes), End User (Ambulatory Care, Diagnostic Laboratories, Home Care), Product Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Blood Glucose Monitoring Market by Application (Gestational Diabetes, Type 1 Diabetes, Type 2 Diabetes), End User (Ambulatory Care, Diagnostic Laboratories, Home Care), Product Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From

About the Point of Care Glucose Testing Market

Point of Care Glucose Testing (POCT) is a type of glucose testing that is performed outside of a laboratory setting. It is typically used to monitor glucose levels in patients with diabetes, and is often used in emergency situations. POCT is a convenient and cost-effective way to measure glucose levels, as it does not require a laboratory or specialized equipment. The results are usually available within minutes, allowing for quick and accurate diagnosis and treatment. POCT is also used to monitor glucose levels in pregnant women, as well as to diagnose and monitor other conditions such as hypoglycemia. The POCT market is growing rapidly, driven by the increasing prevalence of diabetes and other chronic conditions, as well as the need for rapid and accurate diagnosis and treatment. The market is also being driven by technological advancements, such as the development of portable and user-friendly devices. Some companies in the POCT market include Abbott, Roche, Siemens, and LifeScan. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.